print header
Print Page

Investors

Last year's summit attracted over 150 investors from around the world to showcase the 40 most promising Australian biotechnology companies actively seeking capital or partnering opportunities.

An excellent line-up of international and local investors are already confirmed to attend from:

  • Venbio, United States
  • Aisling Capital, United States
  • MedImmune Ventures, United States
  • Biotechnology Value Fund, United States
  • Finsight, Helsinki
  • Next Venture Partners, Korea
  • Paterson Securities
  • DSM Venturing, Nethlands
  • Cowen Royalty Healthcare, United States
  • SpringTree Global Investors, United States
  • Healthcare Ventures, United States
  • Ventures West Capital, Canada
  • Tiburon Partners, London
  • Newstar Ventures
  • One Ventures
  • Ladenburg Thalmann, New York
  • Ignatius Capital Management, United States
  • Genentech, United States
  • Eli Lilly, United States
  • Merck
  • Abbott
  • Roche, China
  • Viriarthus Capital, New York
  • Starfish Ventures
  • RBS Morgans
  • Brandon Capital
  • CM Capital
  • GBS Venture Partners
  • Four Hats Capital
  • Taylor Collison Limited
  • Melbourne Ventures

CLICK HERE to express your interest to attend as an investor. You will be contacted once the Advisory Board has reviewed the expressions of interest.

AusBiotech thanks the following event partners: